VF
ITCI

Virtu Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Virtu Financial’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,738
Closed -$1.42M – 1996
2024
Q2 		$1.42M Buy
+20,738
New +$1.44M 0.1% 207
2024
Q1 		– Sell
-7,623
Closed -$546K – 2241
2023
Q4 		$546K Buy
+7,623
New +$439K 0.04% 382
2022
Q2 		– Sell
-17,143
Closed -$1.05M – 2183
2022
Q1 		$1.05M Buy
+17,143
New +$890K 0.08% 213
2021
Q3 		– Sell
-9,780
Closed -$399K – 2062
2021
Q2 		$399K Buy
+9,780
New +$362K 0.04% 581
2018
Q2 		– Sell
-18,538
Closed -$390K – 2591
2018
Q1 		$390K Buy
+18,538
New +$361K 0.02% 856
2017
Q4 		– Sell
-91,437
Closed -$1.44M – 3126
2017
Q3 		$1.44M Buy
+91,437
New +$1.34M 0.07% 286

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return